russ2000_2_0664|VRCA|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
russ2000_2_0664|VRCA|1|Verrica Pharmaceuticals Inc Total Current Assets (Quarterly) (USD)|Verrica Pharmaceuticals Inc Cash and Short Term Investments (Quarterly) (USD)|Verrica Pharmaceuticals Inc Inventories (Quarterly) (USD)|Verrica Pharmaceuticals Inc Net PP&E (Quarterly) (USD)|Verrica Pharmaceuticals Inc Goodwill and Intangibles (Quarterly) (USD)|Verrica Pharmaceuticals Inc Total Liabilities (Quarterly) (USD)|Verrica Pharmaceuticals Inc Total Current Liabilities (Quarterly) (USD)|Verrica Pharmaceuticals Inc Total Long Term Liabilities (Quarterly) (USD)|Verrica Pharmaceuticals Inc Total Deposits (Quarterly) (USD)|Verrica Pharmaceuticals Inc Book Value (Quarterly) (USD)|Verrica Pharmaceuticals Inc Retained Earnings (Quarterly) (USD)|Verrica Pharmaceuticals Inc Treasury Stock (Quarterly) (USD)|Verrica Pharmaceuticals Inc EV to Revenues|Verrica Pharmaceuticals Inc EV to Earnings|Verrica Pharmaceuticals Inc EV to Free Cash Flow|Verrica Pharmaceuticals Inc EV to Assets (Quarterly)|Verrica Pharmaceuticals Inc PS Ratio|Verrica Pharmaceuticals Inc PE Ratio|Verrica Pharmaceuticals Inc Price to Book Value|Verrica Pharmaceuticals Inc PEG Ratio|Verrica Pharmaceuticals Inc Debt to Equity Ratio|Verrica Pharmaceuticals Inc Dividend Yield|Verrica Pharmaceuticals Inc Shareholder Yield (TTM)|Verrica Pharmaceuticals Inc Percent of Shares Outstanding Short|Verrica Pharmaceuticals Inc Total Receivables (Quarterly) (USD)|Verrica Pharmaceuticals Inc Total Payables (Quarterly) (USD)|Verrica Pharmaceuticals Inc Total Capital Stock (Quarterly) (USD)|Verrica Pharmaceuticals Inc Return on Invested Capital|Verrica Pharmaceuticals Inc Quality Ratio Score|Verrica Pharmaceuticals Inc Momentum Score|Verrica Pharmaceuticals Inc Beta (1Y)|Verrica Pharmaceuticals Inc Sustainable Growth Rate (TTM)|Verrica Pharmaceuticals Inc Institutional Investor Ownership Percentage|Verrica Pharmaceuticals Inc Average Diluted Shares Outstanding (Quarterly)|Verrica Pharmaceuticals Inc Total Employees (Annual)|Verrica Pharmaceuticals Inc EPS Diluted (Quarterly) (USD)|Verrica Pharmaceuticals Inc SG&A Expense (Quarterly) (USD)|Verrica Pharmaceuticals Inc Shares Outstanding|Verrica Pharmaceuticals Inc Repurchase of Capital Stock (Quarterly) (USD)|Verrica Pharmaceuticals Inc Ordinary Shares Number (Quarterly)|Verrica Pharmaceuticals Inc Payout Ratio|Verrica Pharmaceuticals Inc Quick Ratio (Quarterly)|Verrica Pharmaceuticals Inc Normalized Diluted EPS (Quarterly) (USD)|Verrica Pharmaceuticals Inc Stock Buybacks (Quarterly) (USD)|Verrica Pharmaceuticals Inc Effective Tax Rate (TTM)|Verrica Pharmaceuticals Inc Return on Equity|Verrica Pharmaceuticals Inc Net Income (TTM) (USD)|Verrica Pharmaceuticals Inc Revenue (TTM) (USD)|Verrica Pharmaceuticals Inc Dividend Per Share (Quarterly) (USD)|Verrica Pharmaceuticals Inc Revenue (Quarterly) (USD)|Verrica Pharmaceuticals Inc Gross Profit (Quarterly) (USD)|Verrica Pharmaceuticals Inc Pre-Tax Income (Quarterly) (USD)|Verrica Pharmaceuticals Inc Net Income (Quarterly) (USD)|Verrica Pharmaceuticals Inc Net Interest Income (Quarterly) (USD)|Verrica Pharmaceuticals Inc Price (USD)|Verrica Pharmaceuticals Inc Total Return Price (USD)|Verrica Pharmaceuticals Inc Enterprise Value (USD)|Verrica Pharmaceuticals Inc 30-Day Average Daily Volume|Verrica Pharmaceuticals Inc 1 Year Price Returns (Daily)|Verrica Pharmaceuticals Inc Short Interest|Verrica Pharmaceuticals Inc PE Ratio (Forward)|Verrica Pharmaceuticals Inc PE Ratio (Forward 1y)|Verrica Pharmaceuticals Inc PS Ratio (Forward)|Verrica Pharmaceuticals Inc PS Ratio (Forward 1y)|Verrica Pharmaceuticals Inc Quarterly EPS Estimates (USD)|Verrica Pharmaceuticals Inc Quarterly Revenue Estimates (USD)|Verrica Pharmaceuticals Inc Quarterly EPS Surprise|Verrica Pharmaceuticals Inc Quarterly Revenue Surprise|Verrica Pharmaceuticals Inc Quarterly Actual EPS (USD)|Verrica Pharmaceuticals Inc Quarterly Actual Revenue (USD)|Verrica Pharmaceuticals Inc Revenue Estimates for Current Fiscal Year (USD)|Verrica Pharmaceuticals Inc Revenue Estimates for Next Fiscal Year (USD)|Verrica Pharmaceuticals Inc Price Target (USD)|Verrica Pharmaceuticals Inc Consensus Recommendation|Verrica Pharmaceuticals Inc Price Target Num Estimates|Verrica Pharmaceuticals Inc EPS Estimates for Current Fiscal Year (USD)|Verrica Pharmaceuticals Inc EPS Estimates for Next Fiscal Year (USD)|Verrica Pharmaceuticals Inc Research and Development Expense (Quarterly) (USD)|Verrica Pharmaceuticals Inc Reconciled Depreciation (Quarterly) (USD)|Verrica Pharmaceuticals Inc Non-Operating Interest Expense (Quarterly) (USD)|Verrica Pharmaceuticals Inc Land and Improvements (Quarterly) (USD)|Verrica Pharmaceuticals Inc Buildings and Improvements (Quarterly) (USD)|Verrica Pharmaceuticals Inc Other Properties (Quarterly) (USD)|Verrica Pharmaceuticals Inc Machine, Furniture & Equipment (Quarterly) (USD)||
russ2000_2_0664|VRCA|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
russ2000_2_0664|VRCA|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
russ2000_2_0664|VRCA|5|91.2666666667|91.2666666667||91.2666666667||91.2666666667|91.2666666667|91.2666666667||91.2666666667|91.2666666667|91.2666666667|||6.96373056995|91.5|||6.96373056995|||1.4498381877||15.2413793103|91.375|91.2666666667|91.2666666667|||31.5517241379|30.5161290323||30.5|91.3333333333|219.2|91.3333333333|91.3333333333|38.2424242424||91.2666666667|||91.3333333333|91.3529411765|||91.2666666667|||||91.3333333333|91.3333333333|91.3333333333|6.96373056995|6.96373056995|6.96373056995|6.96256684492|6.92907801418|15.2413793103|||1.44755244755|1.44712430427|91.4285714286|91.375|91.3333333333||91.3333333333|91.2857142857|24.4444444444|29.7906976744|29.0909090909|15.6219512195|29.0909090909|24.2093023256|32.025|91.3333333333|91.3125|91.3125||91.375|91.3571428571|91.2666666667||
russ2000_2_0664|VRCA|6|15|15||15||15|15|15||15|15|15|||193|2|||193|||927||87|8|15|15|||29|31||14|18|5|18|18|33||15|||18|17|||15|||||18|18|18|193|193|193|187|141|87|||286|539|7|8|6||6|7|45|43|44|82|44|43|40|18|16|16||8|14|15||
russ2000_2_0664|VRCA|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
russ2000_2_0664|VRCA|201703||||||||||||||||||||||||||||||||||19.9464||-0.0286|0.055||||||-0.0286|||||||||-0.57|-0.57|||||||||||||||||||||||||0.515||||||||
russ2000_2_0664|VRCA|201706||||||||||||||||||||||||||||||||||19.9464||-0.0549|0.118||||||-0.0549|||||||||-1.095|-1.095|||||||||||||||||||||||||0.977||||||||
russ2000_2_0664|VRCA|201709||||||||||||||||||||||||||||||||||19.9464||-0.0681|0.238||||||-0.0681|||||||||-1.359|-1.359|-0.001||||||||||||||||||||||||1.12||0.001||||||
russ2000_2_0664|VRCA|201712|9.083|8.663||||16.124|0.616|15.508||-7.041|-12.435|||||||||||||||0.167||||||||19.9464|11|-0.3377|0.316|||24.9464|||-0.0719||||-4.459|||||-1.435|-1.435|-0.001||||||||||||||||||||||||1.118||0.001||||||
russ2000_2_0664|VRCA|201803|28.905|27.485||0.019||1.648|1.648|||27.748|-14.309|||||||||||||||0.618|0.002|||||||24.9464||-0.074|0.961|24.9464||24.9464|||-0.074||||-5.736|||||-1.847|-1.847|0.041||||||||||||||||||||||||0.927|||||0.019|||
russ2000_2_0664|VRCA|201806|104.59|103.149||0.112||3.125|3.125|||101.591|-20.268||||-77.0484||||18.2839|||||0.1227||1.117|0.003|||||||5.7513|11|-0.92|1.955|25.6964||25.6964|||-0.92|-86.25|||-9.958|||||-5.317|-5.317|0.153|20.3373|20.3373|479.8574|74337.0333||30618|||||||||||||28.3333|1|3||-1.17|3.515|0.005||||0.112||17.6|17.35
russ2000_2_0664|VRCA|201809|98.677|96.975||0.114||2.451|2.451|||96.354|-27.007||||-34.2947||||3.9712|||||0.6617||1.105|0.003|||||||24.8475|15|-0.24|2.865|25.6964||25.6964|||-0.24|7.876|||-14.505|||||-5.906|-5.906|0.427|15.7|15.7|300.2845|100175.4667||170038|||||||||||||28.3333|1|3||-1.25|3.467|0.005||||0.114||12.96|11.36
russ2000_2_0664|VRCA|201812|91.152|89.809||0.255||2.477|2.477|||89.429|-33.083||||-10.7375||||2.3415|||||0.5482||0.96|0.003|||||||25.7048|16|-0.3|3.271|25.7048||25.7048|||-0.3|-7.876|||-20.648|||||-7.578|-7.578|0.61|9.13|9.13|128.6394|44918.3333||140910||||||||||||4.774|26.25|1|4|||4.917|0.01|||||0.076|12.01|10.86
russ2000_2_0664|VRCA|201903|84.677|83.282||1.288||3.218|3.062|0.156||82.761|-40.464||||-10.2792||||3.1074|||||2.389|0.006|1.136|0.003|||||||24.8578||-0.3|3.539|25.7085||25.7085|||-0.3||||-26.28|||||-7.479|-7.479|0.547|10.95|10.95|188.0869|75228.5||614148||||||||||||13.2656|26.25|1.25|4|-1.53|-1.51|4.487|0.011||||0.275|0.076|10.01|8.05
russ2000_2_0664|VRCA|201906|79.739|78.754||1.497||4.405|4.281|0.124||76.845|-47.465||||-6.8579||||2.951|||||2.8177||1.473|0.003|||3|3.9747|||24.8756||-0.28|3.593|25.7403||25.7403|||-0.28||||-27.964|||||-7.001|-7.001|0.523|9.48|9.48|160.9488|38749.7667|-50.763|724394||||||||||||13.2656|27|1.25|4|||3.928|0.011||||0.245|0.076|12.24|9.79
russ2000_2_0664|VRCA|201909|74.04|71.078||2||4.421|4.33|0.091||71.653|-53.555||||-10.5913||||4.1035|||||2.221||1.01|0.003|||3|4.5136|||24.893||-0.24|3.494|25.7448||25.7448|||-0.24||||-28.148|||||-6.09|-6.09|0.453|13.21|13.21|236.5769|57052.9667|-23.2843|571804||||||||||||13.2656|27|1.25|4|-1.15|-1.67|3.049|0.016||||0.178|0.076|13.43|15.71
russ2000_2_0664|VRCA|201912|64.983|62.017||2.201||3.409|3.351|0.058||65.015|-61.192||||-12.4449||||6.3023|||||2.2234||1.185|0.003|||8|5.6428|||24.9648|17|-0.31|4.018|25.7863||25.7863|||-0.31||||-28.207|||||-7.637|-7.637|0.354|16|16|347.7273|89601.1|94.9693|573331||||34.1454|||||||6.8044|37.899||1.25||-1.15||3.972|0.219|||0.111||0.079|14.59|11.81
russ2000_2_0664|VRCA|202003|90.647|88.382||2.42||37.834|3.302|34.532||56.608|-71.014||||-8.5077||||4.9843|||||3.0879||1.103|0.003|||7|2.8626|||24.9642||-0.39|4.988|25.8145||25.8145|||-0.39||||-30.55|||||-9.822|-9.822|0.058|11.66|11.66|228.2045|74858.7|1.1101|797114||||23.5127|-0.355||-9.8592||-0.39||8.0794|45.0923|24.8|1.4|5|-2.34|-1.8567|4.892|0.014|0.22||0.045||0.079|12.07|12.2
russ2000_2_0664|VRCA|202006|83.338|79.622||2.517||38.773|38.698|0.075||48.463|-80.423||||-10.715||||5.8646|||||3.2167||1.297|0.003|||9|1.1649|||24.9656||-0.38|5.11|25.8145||25.8145|||-0.38||||-32.958|||||-9.409|-9.409|-0.778|14.45|14.45|239.3156|54359.8333|-5.2496|830366||||23.6848|-0.4433||14.2851||-0.38||0.0833|20.0485|21.3333|1.3333|6|-2.005|-2.0025|3.521|0.012|0.904||||0.091|6.92|8.86
russ2000_2_0664|VRCA|202009|73.974|71.881||4.599||40.754|39.003|1.751||39.182|-90.909||||-4.9112||||4.3039|||||9.8601||0.179|0.003|||4|1.1071||47.9592|24.9889||-0.42|4.649|25.8655||25.8655|||-0.42||||-37.354|||||-10.486|-10.486|-0.849|7.74|7.74|163.6792|275277.9333|-35.4633|2550374||||16.6832|-0.4333||3.0762||-0.42|||9.836|19|1.4|5|-1.6533|-1.8567|4.988|0.005|0.918|||1.908|0.1|7.43|9.45
russ2000_2_0664|VRCA|202012|67.65|65.47||4.938||41.168|39.475|1.693||32.986|-103.886||||-8.2018||||7.8886|||||6.5362||0.348|0.003|||2|1.3698||49.2573|25.0633|29|-0.52|9.761|25.4411||25.4411|||-0.52||||-42.694|||||-12.977|-12.977|-0.943|11.97|11.97|272.1917|66195.7667|-24.7481|1662886|||24.4023|11.5163|-0.4133||-25.8075||-0.52||9.376|39.7584|20.2|1.4|5|-1.4925|-1.7867|2.272|0.198|0.991||1.836||0.271|12.05|15.16
russ2000_2_0664|VRCA|202103|102.046|87.686||5.109||46.292|44.658|1.634||61.81|-104.822||||-10.8132|3.4178|||11.3945||0.658|||4.3911|11.5|0.878|0.003|||5|1.6237||76.1445|25.6024||-0.04|6.578|27.4907||27.4907||2.221|-0.04|-28.15|||-33.808|||12||-0.936|-0.936|-0.996|15.15|15.15|345.703|116036.9667|19.7898|1207133|||34.707|16.3795|-0.3433||88.3494||-0.04|12|6.97|39.0784|23|1.4|5|-1.81|-1.765|5.362|0.011|1.028|||1.78|0.479|13.35|10.82
russ2000_2_0664|VRCA|202106|93.374|90.129||5.371||46.874|45.282|1.592||52.156|-116.597||||-11.2575|2.4217|||5.1573|||||7.5186||0.783|0.003|||2|2.0809||88.8711|27.5137||-0.43|7.284|27.5147||27.5147|||-0.43|0.031|||-36.174|||||-11.775|-11.775|-1.044|11.3|11.3|271.7566|122479.2333|-17.3419|2068708|||25.9097|12.2277|-0.4075|0.2|-5.5215|-100|-0.43||15.5366|36.7743|21.5|1.5|6|-1.5275|-1.838|3.447|0.037|1.077|||1.723|0.798|11.1|11.48
russ2000_2_0664|VRCA|202109|83.158|79.495||5.334||47.904|46.374|1.53||40.852|-129.426||||-12.4525|2.8292|||6.5732|||||5.3606||0.904|0.003|||5|1.093||41.6215|27.5165||-0.47|8.005|27.5191||27.5191|||-0.47||||-38.517|||||-12.829|-12.829|-1.061|12.31|12.31|293.7092|212131.1|50.6651|1475179|||28.6657|13.5284|-0.51||7.8431||-0.47||9.8|34.3615|19.8333|1.5|6|-1.586|-1.75|3.763|0.054|1.092|||1.666|0.801|12.84|11.11
russ2000_2_0664|VRCA|202112|||||||||||||||-8.5626||||6.2311|||||5.2128||||||6|-0.367||43.1276||||||||||||||||||||||9.53|9.53|216.4047|75935.3667|-20.669|1434503|||11.2826|3.7385|-0.484||||||12|22.342|19.5|1.5|6|-1.408|-1.9783||||||||7.75|7.9